Novanta (STU:1GSN) Dividend-Payout-to-FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:1GSN Novanta Inc STU:1GSN
92 GF Score
Price €117.00
GF Value €137.27
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Novanta Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.

STU:1GSN
92GF Score
Novanta Inc STU:1GSN
Dividend-Payout-to-FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novanta (STU:1GSN) Overvalued in 2026?

Based on GuruFocus' analysis, Novanta stock appears to be undervalued. The current stock price of €117.00 is trading 14.8% below its estimated GF Value™ of €137.27. GuruFocus considers Novanta to be Modestly Undervalued.

Key valuation signals for STU:1GSN:

  • Dividend-Payout-to-FFO:
  • GF Value™: €137.27 vs. price of €117.00 (14.8% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the STU:1GSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novanta Business Description

Other Exchanges NOVT:USANOVTN:Mexico0VAG:UK
Address 125 Middlesex Turnpike, Bedford, MA, USA, 01730
Novanta Inc. is a supplier of core technology components and subsystems to original equipment manufacturers in the medical, life sciences, and advanced industrial markets. The company operates through two segments: Automation Enabling Technologies, which provides laser beam steering and scanning solutions, laser sources, and precision motion and robotic technologies, and Medical Solutions, which offers medical-grade technologies such as insufflators, endoscopic pumps, and integrated operating room systems. Its customers are primarily OEMs that integrate these components into their own products. Novanta generates revenue mainly from the United States, with additional operations and sales across Europe and Asia, including Germany and other markets. The Automation Enabling Technologies segment accounts for the majority of revenue. The company's products support applications in precision medicine, precision manufacturing, robotics and automation, and advanced surgery.
92GF Score

Get the complete analysis for STU:1GSN

Dividend-Payout-to-FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€117.00
Price
€137.27
GF Value